Cancer of the Upper Aero-digestive Tract and Socio-professional Future

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

46 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-02-28

Study Completion Date

2018-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to explore the main factors associated with the return to work of patients presenting an upper aero-digestive tract cancer.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Predictive Factors of Survival With and Without Repetition With 5 and 10 Years Curative Post-oesophagectomy for Cancer of the Oesophagus

NCT03410758

Esophageal Cancer Esophageal Surgery Cancer Overall Survival

COMPLETED

A Questionnaire Survey for Biliary Tract Cancers

NCT04731220

Biliary Tract Cancer

ENROLLING_BY_INVITATION

Detection and Automatic Segmentation of Liver Nodules in Patients With Colorectal Adenocarcinoma

NCT04834596

Detection of Liver Metastases

UNKNOWN

A Feasibility Study of Direct Access to an Abdominal ´Yes-No´ Pathway for Primary Care Patients

NCT03878940

Cancer Primary Health Care

COMPLETED NA

Prognostic Value of Tissue Factor (TF) in Blood t in Colorectal Cancer in Adults

NCT02304978

Colorectal Cancer

COMPLETED EARLY_PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Socio-professional, medical, psychological, demographic, economic, and educational data collection in patients within the care pathway of upper aero-digestive tract cancer.

A series of questionnaires will be presented at the initial consultation and then at 6 months, at 12 months and at 18 months during follow-up visits. Medical data will be collected via the CRF.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Upper Aerodigestive Tract Neoplasms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Questionnaires

completion of questionnaires

Group Type EXPERIMENTAL

Questionnaires

Intervention Type BEHAVIORAL

A first series of questionnaires will be given by the investigator at patients before treatment (inclusion visit) and then the questionnaires will be given at the follow-up visits planned at 6 months, 12 months and 18 months.

Medical data will be collected via the CRF.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaires

A first series of questionnaires will be given by the investigator at patients before treatment (inclusion visit) and then the questionnaires will be given at the follow-up visits planned at 6 months, 12 months and 18 months.

Medical data will be collected via the CRF.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age at diagnosis ≥ 18 to ≤ 55 years
* Employed at the entry into the care pathway
* Presenting an upper aero-digestive tract cancer (excluding nasal cavities), stage I, II and III, under a first anti-tumor treatment (surgery, radiotherapy, or chemotherapy)
* Patient mastering the French language
* Affiliated to the social security system
* Consent signed by the patient before the implementation of any specific study procedure

Exclusion Criteria

* Having been treated for another cancer before (except skin cancer and / or prostate)
* Metastatic disease from the outset
* Patient unable to submit to a regular follow-up
* Presenting psychiatric disorders

Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No